Autoimmunity versus tolerance: Analysis using transgenic mice

Human Immunology

Volumn 61, Issue 12, 2000, Pages 1383-1389

  Taneja, Veena ^a   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Collagen induced arthritis; Immunotherapy; Major histocompatibility complex; Rheumatoid arthritis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; GENETIC PREDISPOSITION; HLA SYSTEM; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COLLAGEN; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES;

EID: 0034490074     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00208-1     Document Type: Article

References (26)

1. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a synnergic or semiallogemic system
2. Ligand motifs of HLA-DRB5*0101 and DRBI*1501 molecules delineated from self-peptides
3. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
4. Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From shared epitope hypothesis to a peptidic model of rheumatoid arthritis
5. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis
6. HLA-DQB3.1 is a determinant of susceptibility to DR4 associated rheumatoid arthritis
7. HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis
8. Tolerance to a self-peptide from the third hypervariable region of HLA-DRB1*0401 in rheumatoid arthritis patients and normal subjects
9. HLA-DQ8 transgenic mice are highly susceptible to collagen induced arthritis: A novel model for human polyarthritis
10. Mice lacking MHC class II molecules
11. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis
12. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide
13. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism
14. Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling
15. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice
16. HLA-DQ binding motifs: Comparative analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes
17. Structural aspects of the interaction between heterogeneic human papillomavirus type 1 E4-specific T cell receptors and the same peptide/HLA-DQ8 complex
18. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis
19. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis
20. HLA-DQB1 polymorphism determine incidence, onset and severity of collagen-induced arthritis (CIA) in transgenic mice: Implications in human rheumatoid arthritis
21. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: Implications for rheumatoid arthritis predisposition
22. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8
23. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase
24. T cell tolerance by clonal elimination in the thymus
25. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice
26. Identification of HLA class II-restricted determinants of mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice